Ventricular Arrhythmias After Pulmonary Vein Isolation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

111 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-10-31

Study Completion Date

2017-01-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators study aimed to observe the occurrence of new premature ventricular complexes and other ventricular arrhythmias after pulmonary vein isolation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Concealed Myocardial Abnormalities by Cardiac Magnetic Resonance Imaging in Idiopathic VT

NCT06146556

Premature Ventricular Contractions

ACTIVE_NOT_RECRUITING

QT Interval in Patients With Pacemaker Dependency

NCT01694550

High Degree AV-block Left Bundle Branch Block

COMPLETED

Recurrent Ventricular Arrythmias in ICU

NCT07033065

Ventricular Arrythmia Cardiogenic Shock Electrical Storm

NOT_YET_RECRUITING

Relieving the Emergency Department by Using a 1-lead ECG Device for Atrial Fibrillation Patients After Pulmonary Vein Isolation

NCT06283654

Atrial Fibrillation

COMPLETED

Characterization of Arrhythmia-induced Cardiomyopathy

NCT05662293

Cardiomyopathy Arrhythmia-induced Cardiomyopathy (AiCM)

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Atrial fibrillation is the most common arrhythmia with a lifetime risk for development of over 20%. Pulmonary vein isolation is now established as therapy of choice for patients with symptomatic atrial fibrillation. It is well known that this interventional therapy inevitably modulates the intracardiac autonomic nervous system. While this ablation might alter atrial electrophysiology beneficially, the impact on ventricular electrophysiology remains unclear.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ventricular Arrhythmias Atrial Fibrillation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \> 18 years
* Paroxysmal atrial fibrillation scheduled to undergo pulmonary vein isolation

Exclusion Criteria

* Age \< 18 years
* Persistent atrial fibrillation
* Life expectancy less than 12 months
* Acute myocardial infarction, coronary artery bypass graft surgery, open heart surgery, or percutaneous transluminal coronary angioplasty within less than 3 months prior to inclusion
* Documentation of \>30 premature ventricular complexes per hour, salvos or ventricular tachycardias prior to atrial fibrillation ablation

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No